Contact
searchSearch
HMP Global

Vascular Disease Management

Recently Published

Dr Craig Walker
Clinical Editor's Corner
Rethinking Lesion Preparation
11/11/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Watch as Clinical Editor Dr Craig Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation".
Watch as Clinical Editor Dr Craig Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation".
Watch as Clinical Editor Dr...
11/11/2026
Vascular Disease Management
Stroke Prevention
FDA Approval of Asundexian Provides a New Approach to Secondary Stroke Prevention
11/10/2026
Asundexian (Sunharbo; Bayer) gives clinicians a new option: a once-daily oral Factor XIa inhibitor added to antiplatelet therapy to reduce the risk of stroke in adults with recent noncardioembolic ischemic stroke or high-risk TIA.
Asundexian (Sunharbo; Bayer) gives clinicians a new option: a once-daily oral Factor XIa inhibitor added to antiplatelet therapy to reduce the risk of stroke in adults with recent noncardioembolic ischemic stroke or high-risk TIA.
Asundexian (Sunharbo; Bayer)...
11/10/2026
Vascular Disease Management
Clinical Editor's Corner
Decades of Progress, Persistent Challenges: Rethinking Lesion Preparation
11/10/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation”.
Dr Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation”.
Dr Walker comments on Dr Michael...
11/10/2026
Vascular Disease Management
Abstracts
Symposium on Clinical Interventional Oncology 2026 Abstracts
11/04/2026
Vascular Disease Management is pleased to publish the accepted abstracts from the upcoming Symposium on Clinical Interventional Oncology (CIO).
Vascular Disease Management is pleased to publish the accepted abstracts from the upcoming Symposium on Clinical Interventional Oncology (CIO).
Vascular Disease Management is...
11/04/2026
Vascular Disease Management
Fortegra
Sponsored Video
GORE® VIABAHN® FORTEGRA Venous Stent
11/01/2026
The FORTEGRA Venous Stent is purpose-built for the treatment of IVC obstruction, with or without combined iliofemoral obstruction.
The FORTEGRA Venous Stent is purpose-built for the treatment of IVC obstruction, with or without combined iliofemoral obstruction.
The FORTEGRA Venous Stent is...
11/01/2026
Vascular Disease Management
Luis A Sanchez, MD
Sponsored Video
Advancing Endovascular Off-the-Shelf Options for Visceral Aortic Repair
11/01/2026
Luis A. Sanchez, MD
Dr Luis Sanchez discusses patient selection criteria for treatment of thoracoabdominal aortic aneurysms and his experiences with the GORE® EXCLUDER® TAMBE.
Dr Luis Sanchez discusses patient selection criteria for treatment of thoracoabdominal aortic aneurysms and his experiences with the GORE® EXCLUDER® TAMBE.
Dr Luis Sanchez discusses...
11/01/2026
Vascular Disease Management
Sponsored Case Study
Embolization of Hypervascular Tumors Using the Embrace® Hydrogel Embolic System
10/30/2026
Edgar St. Amour, MD; Joseph S. Bittle, MD
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2...
10/30/2026
Vascular Disease Management
Review
FLEX Vessel Prep System for Lesion Preparation
10/21/2026
Michael Lichtenberg, MD, FESC
The FLEX Vessel Prep (FLEX VP) System (Flex Vascular) represents a different concept of lesion preparation. Rather than relying primarily on high radial balloon pressure or tissue removal, FLEX VP uses controlled longitudinal microincisions...
The FLEX Vessel Prep (FLEX VP) System (Flex Vascular) represents a different concept of lesion preparation. Rather than relying primarily on high radial balloon pressure or tissue removal, FLEX VP uses controlled longitudinal microincisions...
The FLEX Vessel Prep (FLEX VP)...
10/21/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
Primary Outcomes of the MOTIV BTK Sirolimus-Eluting Bioresorbable Vascular Scaffold for the Treatment of Infrapopliteal Lesions
10/20/2026
Tim Wittig, MD
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his...
10/20/2026
Vascular Disease Management
Advertorial
Creating a New Path for Long, Heavily Calcified Femoropopliteal Occlusions With the DETOUR™ System
10/14/2026
Ramzan M. Zakir, MD, RPVI, FACC, FSCAI; Haris Umer Usman, MD, MS, FACC, FSCAI
Drs Zakir and Usman discuss the DETOUR™ System.
Drs Zakir and Usman discuss the DETOUR™ System.
Drs Zakir and Usman discuss the...
10/14/2026
Vascular Disease Management

Interventional Oncology

Abstracts
Symposium on Clinical Interventional Oncology 2026 Abstracts
11/04/2026
Vascular Disease Management is pleased to publish the accepted abstracts from the upcoming Symposium on Clinical Interventional Oncology (CIO).
Vascular Disease Management is pleased to publish the accepted abstracts from the upcoming Symposium on Clinical Interventional Oncology (CIO).
Vascular Disease Management is...
11/04/2026
Vascular Disease Management
Sponsored Case Study
Embolization of Hypervascular Tumors Using the Embrace® Hydrogel Embolic System
10/30/2026
Edgar St. Amour, MD; Joseph S. Bittle, MD
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2...
10/30/2026
Vascular Disease Management
Peripheral Arterial Bleeds
Instylla's Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds
10/29/2026
10/29/2026
Vascular Disease Management
Deep Learning
Deep Learning Model Predicts Hepatocellular Carcinoma Progression Following Transarterial Chemoembolization
10/09/2026
Laura Simson, MA
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.
A prediction model combining...
10/09/2026
Vascular Disease Management
TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
JANE-2 project
Green Paper
Tumor Ablation Review Maps Next Phase of Cancer Care
08/14/2026
Laura Simson, MA
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of...
08/14/2026
Vascular Disease Management
Phase 3 Randomized Clinical Trial
TACE Plus Ablation Improves Survival in Unresectable HCC Compared With TACE Alone
08/11/2026
Laura Simson, MA
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency...
08/11/2026
Vascular Disease Management
Liver Tumor Ablation
First Meta-analysis Supports Histotripsy for Liver Tumor Ablation
07/14/2026
Laura Simson, MA
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high...
07/14/2026
Vascular Disease Management
GPX Embolic Device
GPX® Embolic Device Meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
07/14/2026
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx...
07/14/2026
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management

International Symposium on Endovascular Therapy

Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Fabrizio Fanelli speaks at ISET 2026.
ISET 2026
What Is the Role of Specialty Balloons in the Tibial Vessels?
03/30/2026
Fabrizio Fanelli, MD
In this video from ISET 2026, Fabrizio Fanelli, MD, from Careggi University Hospital in Florence, Italy, explores the evolving role of specialty balloons in the treatment of tibial vessel disease.
In this video from ISET 2026, Fabrizio Fanelli, MD, from Careggi University Hospital in Florence, Italy, explores the evolving role of specialty balloons in the treatment of tibial vessel disease.
In this video from ISET 2026,...
03/30/2026
Journal of Critical Limb Ischemia
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management

The Amputation Prevention Symposium

Tim Wittig, MD
AMP 2026
Primary Outcomes of the MOTIV BTK Sirolimus-Eluting Bioresorbable Vascular Scaffold for the Treatment of Infrapopliteal Lesions
10/20/2026
Tim Wittig, MD
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his presentation on the MOTIV BTK sirolimus-eluting bioresorbable vascular scaffold (REVA Medical).
Dr Tim Wittig fdiscusses his...
10/20/2026
Vascular Disease Management
Zola N'Dandu, MD
AMP 2026
Unmet Needs in Deep Venous Arterialization Technology
10/07/2026
Zola N'Dandu, MD
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.
Zola N'Dandu, MD, discusses one...
10/07/2026
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
Healing That Lasts: Real-World 90-Day Outcomes Demonstrating the Durability of Serration Remodeling Therapy
10/06/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses his AMP 2026 presentation on serration remodeling therapy.
Mike Watts, MD, FSIR, discusses...
10/06/2026
Vascular Disease Management
Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management

Office-Based Labs (OBL) Corner

Review
Safety of Outpatient Endovascular Interventions for Peripheral Arterial Disease: Evidence and Applications for U.S. Practice
08/12/2026
Naina G. Subherwal; Simran P. Subherwal; Sreejit Nair, MD; Ashwani Sastry, MD
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31...
08/12/2026
Vascular Disease Management
MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
Clinical Editor's Corner
Ensuring Safety and Effectiveness in Outpatient Settings
01/16/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article...
01/16/2026
Vascular Disease Management
Review
Safety in Office-Based Laboratories and Ambulatory Surgery Centers
01/15/2026
Krishna Jain, MD, FACS
The author summarizes evidence that endovascular procedures in OBLs and ASCs achieve safety outcomes comparable to hospitals when standardized policies and compliance are in place.
The author summarizes evidence that endovascular procedures in OBLs and ASCs achieve safety outcomes comparable to hospitals when standardized policies and compliance are in place.
The author summarizes evidence...
01/15/2026
Vascular Disease Management
Bret Wiechmann, MD
OBL Corner
Is There an Optimal Site of Service for CLTI Intervention: Hospital, ASC, or OBL?
09/04/2025
Bret N. Wiechmann, MD, FSIR, FAHA; Mike Watts, MD, FSIR
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike Watts discuss the differences between hospitals, ambulatory surgery centers, and office-based labs when dealing with CLTI interventions.
Drs Bret Wiechmann and Mike...
09/04/2025
Vascular Disease Management
OBL Corner
OBL Spotlight: Joint & Vascular Institute
08/22/2025
Osman Ahmed, MD
VDM spoke with interventional radiologist Osman Ahmed, MD, FSIR, FCIRSE, about the Joint & Vascular Institute, a new OBL in Libertyville, Illinois, that he started with Mikin V. Patel, MD, MBA.
VDM spoke with interventional radiologist Osman Ahmed, MD, FSIR, FCIRSE, about the Joint & Vascular Institute, a new OBL in Libertyville, Illinois, that he started with Mikin V. Patel, MD, MBA.
VDM spoke with interventional...
08/22/2025
Vascular Disease Management
Teri Yates
AMP 2025
The Pros and Cons of OBLs and ASCs
08/15/2025
Teri Yates
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable...
08/15/2025
Vascular Disease Management

Editor's Corner

Clinical Editor's Corner
Decades of Progress, Persistent Challenges: Rethinking Lesion Preparation
11/10/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation”.
Dr Walker comments on Dr Michael Lichtenberg’s article “FLEX Vessel Preparation System for Lesion Preparation”.
Dr Walker comments on Dr Michael...
11/10/2026
Vascular Disease Management
Clinical Editor's Corner
Expanding the Role of Embolic Protection in Peripheral Arterial Interventions
03/17/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary...
03/17/2026
Vascular Disease Management
Clinical Editor's Corner
Ensuring Safety and Effectiveness in Outpatient Settings
01/16/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article...
01/16/2026
Vascular Disease Management
Clinical Editor's Corner
Changing the Present Algorithm of Evaluation and Therapy of Chronic Limb-Threatening Ischemia
11/20/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
Dr Walker discusses the article...
11/20/2025
Vascular Disease Management
Clinical Editor's Corner
A Cost Analysis of Venous Thromboembolism Treatment
10/14/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker...
10/14/2025
Vascular Disease Management
Editor's Corner
DVA Shows Great Promise in Saving Limbs, Saving Lives, and Reducing Healthcare Costs
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the...
09/19/2025
Vascular Disease Management
Editor's Corner
The Importance of Simulation Training in Modern Medical Education
08/19/2024
Matthew T. Finn, MD, MS
Dr. Matthew Finn discusses the article by Soliman et al, “The Impact of Early Vascular Simulation Training in Medical School Education.”
Dr. Matthew Finn discusses the article by Soliman et al, “The Impact of Early Vascular Simulation Training in Medical School Education.”
Dr. Matthew Finn discusses the...
08/19/2024
Vascular Disease Management
Editor's Corner
Screening for Peripheral Arterial Disease
12/15/2023
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner,...
12/15/2023
Vascular Disease Management
Editor's Corner
Atherectomy in the Infrainguinal Arteries
10/30/2023
McCall Walker, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Sahil A. Parikh, MD, FACC, FSCAI; Matthew T. Finn, MD, MS
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports...
10/30/2023
Vascular Disease Management
Editor's Corner
Addressing the New York Times Controversy: Eroding Patient Trust
09/20/2023
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr. Walker discusses the recent controversy over the New York Times article on atherectomy.
Dr. Walker discusses the recent controversy over the New York Times article on atherectomy.
Dr. Walker discusses the recent...
09/20/2023
Vascular Disease Management

Clinical Insights

Sponsored Case Study
Embolization of Hypervascular Tumors Using the Embrace® Hydrogel Embolic System
10/30/2026
Edgar St. Amour, MD; Joseph S. Bittle, MD
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2 low-viscosity liquid precursors that crosslink intravascularly when simultaneously injected through a coaxial microcatheter system.
Embrace® HES consists of 2...
10/30/2026
Vascular Disease Management
Case Report
Successful Recanalization of a Superficial Femoral Artery Chronic Total Occlusion Using the Santreva-ATK Endovascular Revascularization Catheter
10/12/2026
Angelo Caputi Zuniga, MD; Sudhir Mungee, MD
This case report discusses a 67-year-old man with lifestyle-limiting claudication and a resting left ankle-brachial index of 0.52 secondary to a 60-mm, moderately-to-severely calcified superficial femoral artery CTO.
This case report discusses a 67-year-old man with lifestyle-limiting claudication and a resting left ankle-brachial index of 0.52 secondary to a 60-mm, moderately-to-severely calcified superficial femoral artery CTO.
This case report discusses a...
10/12/2026
Vascular Disease Management
Case Report
Limb Salvage Utilizing the DETOUR Procedure in Dense Calcific Multilevel Disease
10/05/2026
Mikael Fadoul, MD
This case report describes the use of the DETOUR system to successfully treat a dense calcific TASC D lesion with associated tissue loss and ultimate limb salvage.
This case report describes the use of the DETOUR system to successfully treat a dense calcific TASC D lesion with associated tissue loss and ultimate limb salvage.
This case report describes the...
10/05/2026
Vascular Disease Management
Case Report
Restoring Mobility in Complex Diabetic Peripheral Arterial Disease
09/15/2026
Stavros Spiliopoulos, MD, PhD; Stavros Grigoriadis, MD, MSc, PhD; Konstantinos Palialexis, MD, MSc, PhD; Constantine N. Antonopoulos, MD, PhD; George S. Sfyroeras, MD, PhD
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a...
09/15/2026
Vascular Disease Management
Case Report
Revascularizing Femoropopliteal Chronic Total Occlusions With Atheroplasty: A Case-Based Discussion
08/13/2026
Michael Lichtenberg MD; Stefan Stahlhoff, MD
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the application of the Santreva-ATK system (AngioSafe) in a complex femoropopliteal CTO.
This case illustrates the...
08/13/2026
Vascular Disease Management
Case Report
Extreme Limb Salvage Facilitated by Patient Advocacy, Multidisciplinary Care, and a Novel Stabilized Hypochlorous Acid Wound Therapy
07/22/2026
David E. Allie, MD; Kerry T. Thibodeaux, MD; Amit Amin, MD; Kym McNicholas
This case report describes an extreme limb salvage outcome.
This case report describes an extreme limb salvage outcome.
This case report describes an...
07/22/2026
Vascular Disease Management
Case Report
Off-Label Flow Diverter Stent as a Salvage Technique for Early Post-Liver Transplant Hepatic Arterial Occlusion: A Novel Technique
07/15/2026
Santhosh Babu K.B, MBBS, MD, FNVIR; Ashish Goel, DM, MD; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case...
07/15/2026
Vascular Disease Management
Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
Original Research
Association Between Peak Anti-Xa Activity and Bleeding Events in Patients Treated With NOACs
01/19/2026
Alberto Francesco Cereda, MD; Marco Biolcati, MD; Federico Biondi, MD; Marco Stracqualursi, MD; Antonio Gabriele Franchina, MD; Lorenzo Tua, MD; Stefano Lucreziotti, MD
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
This meta-analysis assesses the...
01/19/2026
Vascular Disease Management
Case Report
Femoral Vein Reconstruction: A Complicated Case Example Treating Chronic Venous Disease With a Modified Gun-Sight Technique
12/02/2025
Matthew Tiede, MD
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of...
12/02/2025
Vascular Disease Management

About Us

Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies. 

Learn more about ISET and AMP and register for the events here:

ISET logo

AMP logo

Subscribe Now!

Vascular Disease Management Newsletter

News

Carotid REvascularization
Contego Medical Receives FDA Approval for Neuroguard IEP Direct System for Transcarotid Artery Revascularization with Integrated Embolic Protection (TCAR-IEP)
11/11/2026
The Neuroguard IEP 3-in-1 system was previously studied for transfemoral and transradial carotid stenting in the PERFORMANCE I and PERFORMANCE II studies. It received FDA PMA approval in October 2024 and is commercially distributed by...
The Neuroguard IEP 3-in-1 system was previously studied for transfemoral and transradial carotid stenting in the PERFORMANCE I and PERFORMANCE II studies. It received FDA PMA approval in October 2024 and is commercially distributed by...
The Neuroguard IEP 3-in-1 system...
11/11/2026
Cath Lab Digest
Stroke Prevention
FDA Approval of Asundexian Provides a New Approach to Secondary Stroke Prevention
11/10/2026
Asundexian (Sunharbo; Bayer) gives clinicians a new option: a once-daily oral Factor XIa inhibitor added to antiplatelet therapy to reduce the risk of stroke in adults with recent noncardioembolic ischemic stroke or high-risk TIA.
Asundexian (Sunharbo; Bayer) gives clinicians a new option: a once-daily oral Factor XIa inhibitor added to antiplatelet therapy to reduce the risk of stroke in adults with recent noncardioembolic ischemic stroke or high-risk TIA.
Asundexian (Sunharbo; Bayer)...
11/10/2026
Vascular Disease Management
LAA Occluders
Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/03/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions;data show the device achieved high closure rates of...
Late-breaking one-year...
11/03/2026
Vascular Disease Management
Intravascular Lithotripsy
Abbott's TECTONIC Clinical Trial Demonstrates Strong 30-day Outcomes and High Procedural Success for Its Investigational SonicForce™ Coronary Intravascular Lithotripsy System
11/03/2026
11/03/2026
Vascular Disease Management
Stroke Clinical Trials
Could A Drug for Leg Cramps Prevent a Second, Deadlier Stroke? 
10/30/2026
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the National Institute of Neurological Disorders and Stroke (NINDS) and is open to patients diagnosed within the last six months with an ischemic stroke or high-risk transient ischemic attack (TIA).
The trial is funded by the...
10/30/2026
Cath Lab Digest
Radiation Safety
Rampart Launches Vanguard™ at TCT 2026, Extending Total-Body Radiation Protection to Interventional Imagers
10/29/2026
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table solution advances the Shed the Lead® movement as new multisociety guidance calls for enhanced radiation protection.
Purpose-built head-of-table...
10/29/2026
Vascular Disease Management
Peripheral Arterial Bleeds
Instylla's Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds
10/29/2026
10/29/2026
Vascular Disease Management
Large-Bore Closure
Haemonetics Announces FDA Approval of PerQseal Elite Vascular Closure System
10/27/2026
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system provides sutureless, large-bore vascular closure following structural heart and endovascular procedures performed with 14 – 22F sheaths. Its fully bioabsorbable patch seals arteriotomies up to 26F from within the...
The PerQseal Elite system...
10/27/2026
Cath Lab Digest
FDA Approvals
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
10/20/2026
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra,...
10/20/2026
Cath Lab Digest
Vertex PE System (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients
10/19/2026
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the...
10/19/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use